|Articles|December 7, 2011
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2011
- Volume 7
- Issue 12
Technical Perspectives: Antibody Drug Conjugates
Author(s)Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Advertisement
Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the
Articles in this issue
over 14 years ago
CSR and Sustainability in the Newsover 14 years ago
Pharmaceutical Companies Target Green Manufacturingover 14 years ago
Biosimilars' Technology NeedsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly Roundup—July 24, 2026
2
Peptide Compounding Vote Raises New Questions for Drug Developers
3
What Jideytro's Approval Means for Drug Developers
4
Midyear 2026 Check-In: AI Investment Skipped Pharma's Costliest Operational Problem
5